1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Neurotec Pharma: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase IIa Study of NT-KO-003 for Multiple Sclerosis NT-KO-003 - Relapsing Remitting Multiple Sclerosis | Phase 2 | Completed | Neurotec Pharma | 99 | 2011-06-01 | 2014-03-18 |
Multiple Sclerosis, Relapsing-Remitting (1)
Germany (1) · Spain (1)